These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8648890)

  • 1. [Problems of the amyloid beta precursor protein in pathogenesis of the Alzheimer type dementia].
    Shoji M; Hirai S
    Nihon Ronen Igakkai Zasshi; 1996 Mar; 33(3):164-8. PubMed ID: 8648890
    [No Abstract]   [Full Text] [Related]  

  • 2. [Beta/A4-type amyloid protein in Alzheimer's disease and cerebral amyloid angiopathies].
    Hirai S; Okamoto K
    Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1424-9. PubMed ID: 8245639
    [No Abstract]   [Full Text] [Related]  

  • 3. Alzheimer's disease and amyloid.
    Robertson M
    Nature; 1992 Mar; 356(6365):103. PubMed ID: 1545855
    [No Abstract]   [Full Text] [Related]  

  • 4. A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor.
    Lu DC; Rabizadeh S; Chandra S; Shayya RF; Ellerby LM; Ye X; Salvesen GS; Koo EH; Bredesen DE
    Nat Med; 2000 Apr; 6(4):397-404. PubMed ID: 10742146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid cerebral amyloid binding by Aβ antibodies infused into β-amyloid precursor protein transgenic mice.
    Winkler DT; Abramowski D; Danner S; Zurini M; Paganetti P; Tolnay M; Staufenbiel M
    Biol Psychiatry; 2010 Nov; 68(10):971-4. PubMed ID: 20359696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulation of AβPP processing alleviates amyloid-β-related pathology in Alzheimer's disease transgenic mice.
    Arbel-Ornath M; Becker M; Rabinovich-Toidman P; Gartner M; Solomon B
    J Alzheimers Dis; 2010; 22(2):469-82. PubMed ID: 20847413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.
    Games D; Adams D; Alessandrini R; Barbour R; Berthelette P; Blackwell C; Carr T; Clemens J; Donaldson T; Gillespie F
    Nature; 1995 Feb; 373(6514):523-7. PubMed ID: 7845465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease.
    Garcia-Alloza M; Robbins EM; Zhang-Nunes SX; Purcell SM; Betensky RA; Raju S; Prada C; Greenberg SM; Bacskai BJ; Frosch MP
    Neurobiol Dis; 2006 Dec; 24(3):516-24. PubMed ID: 17029828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of the Alzheimer's disease phenotype by absence of 12/15-lipoxygenase.
    Yang H; Zhuo JM; Chu J; Chinnici C; Praticò D
    Biol Psychiatry; 2010 Nov; 68(10):922-9. PubMed ID: 20570249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
    Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
    J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer's disease.
    Grimm MO; Kuchenbecker J; Rothhaar TL; Grösgen S; Hundsdörfer B; Burg VK; Friess P; Müller U; Grimm HS; Riemenschneider M; Hartmann T
    J Neurochem; 2011 Mar; 116(5):916-25. PubMed ID: 21214572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 7th Leonard Berg Symposium, Part 3.
    Strobel G
    J Alzheimers Dis; 2010; 21(1):315-21. PubMed ID: 20657051
    [No Abstract]   [Full Text] [Related]  

  • 14. Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models.
    Mi W; Pawlik M; Sastre M; Jung SS; Radvinsky DS; Klein AM; Sommer J; Schmidt SD; Nixon RA; Mathews PM; Levy E
    Nat Genet; 2007 Dec; 39(12):1440-2. PubMed ID: 18026100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.
    Ribé EM; Pérez M; Puig B; Gich I; Lim F; Cuadrado M; Sesma T; Catena S; Sánchez B; Nieto M; Gómez-Ramos P; Morán MA; Cabodevilla F; Samaranch L; Ortiz L; Pérez A; Ferrer I; Avila J; Gómez-Isla T
    Neurobiol Dis; 2005 Dec; 20(3):814-22. PubMed ID: 16125396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation.
    Koistinaho M; Kettunen MI; Goldsteins G; Keinänen R; Salminen A; Ort M; Bures J; Liu D; Kauppinen RA; Higgins LS; Koistinaho J
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1610-5. PubMed ID: 11818564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice.
    Grueninger F; Bohrmann B; Czech C; Ballard TM; Frey JR; Weidensteiner C; von Kienlin M; Ozmen L
    Neurobiol Dis; 2010 Feb; 37(2):294-306. PubMed ID: 19781645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease.
    Querfurth HW; LaFerla FM
    N Engl J Med; 2010 Jan; 362(4):329-44. PubMed ID: 20107219
    [No Abstract]   [Full Text] [Related]  

  • 19. [Internalization of beta amyloid protein in primary cultured cortical neurons in mouse].
    Qian YH; Shi LL; Yang J; Hu XD; Han H; Liu Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Nov; 33(11):1019-27. PubMed ID: 19060370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomedicine. Tauists and beta-aptists united--well almost!
    Lee VM
    Science; 2001 Aug; 293(5534):1446-7. PubMed ID: 11520974
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.